|
7th May 2008
Toroed, Norway
AME Bioscience and Fluidigm team up in Nordic distribution deal.
Arrangement Brings Integrated Fluidic Circuit Technology to
Nordic Scientists Specializing in Real-Time PCR, Genotyping,
Cancer Detection and Absolute Quantification.
SOUTH SAN FRANCISCO, Calif., TOROED, Norway, April 18, 2008 – Fluidigm Corporation, the industry leader in integrated fluidic circuit technology, has appointed AME Bioscience as its exclusive distributor for the BioMark™ Molecular Biology Systems in the Nordic Region (Norway, Sweden, Iceland, Finland, and Denmark). The BioMark System is ideal for real-time PCR, genotyping, cancer detection, and absolute quantification.
Fluidigm’s BioMark System – using dynamic arrays -- provides orders-of-magnitude better throughput and efficiency when validating gene- or SNP-based biomarkers by PCR when compared to conventional real-time PCR and genotyping platforms.
The BioMark System -- using digital arrays -- divides a mixture of sample and PCR reagents into hundreds (or thousands) of replicates. This digital array is specially designed to quantify target sequences very accurately and to detect low-abundance targets that differ by only a base-pair from the wild-type sequence. Using Fluidigm’s digital arrays, scientists can find the rare somatic-cell mutation that indicates the onset of disease. Using absolute quantification – comparing the PCR cycle thresholds of unknown targets to standard PCR curve -- Fluidigm’s digital arrays can, for example, detect how viral loads change in response to treatments, or how efficient a given gene-therapy delivery vector is, or assess the quality of agricultural seed products.
The Fluidigm BioMark System can provide scientists these answers at a fraction of the labor and running cost when compared with conventional systems.
The BioMark System utilizes integrated fluidic circuits that contain a microscopic matrix of channels, valves and chambers on a silicone based chip that can automatically perform over two thousand experiments at a time.
“Fluidigm is committed to bringing the accuracy and efficiency benefits of integrated fluidic circuit technology to life science researchers in the Nordic Region,” said Dominique Remy-Renou, European Vice President of Sales, Fluidigm. “We are confident that this partnership with AME Bioscience will bring our industry-leading technology and products along with AME’s first-rate customer support to the scientists of this region.”
“We are thrilled to partner with an innovation leader such as Fluidigm to bring the very best in life science technology to our customers,” said Alister Ewing, Director AME Bioscience. “We hope to serve as the catalyst in bringing the benefits of integrated fluidic circuit technology and Fluidigm’s BioMark System to Nordics researchers and help them continue to bring new life science breakthroughs to the world.”
About Fluidigm Corporation. Fluidigm Corporation develops and distributes systems based on the unique properties of Integrated Fluidic Circuits (IFCs) to precisely control fluids on a nano volume scale. The company brings IFCs’ unparalleled efficiencies to the life science and allied fields.
Fluidigm, the Fluidigm logo, and BioMark are trademarks or registered trademarks of Fluidigm Corporation in the U.S. and/or other countries.
Further details are available by contacting AME Bioscience.
Telephone:
Norway 33 610 718
Denmark 36 98 82 95
Finland 09 2316 3263
Sweden 08 519 70 401
Iceland +47 33 610 718
About AME Bioscience AME Bioscience (established 2002) is a privately owned life science company with offices and employees in Norway, Sweden, UK and Germany and an affiliate in the USA. The company is dedicated to develop sell and support products that simplify the methods used for DNA & Protein research and diagnostics. The people behind AME Bioscience have their industrial experience from Applied Biosystems, Pyrosequencing, Gyros and Philips Medical.The AME Bioscience team has previously had success with developing and supporting international markets for automated nucleic acid analysis products for research, clinical and diagnostic laboratories. Further details are available by contacting
AME Bioscience
Nordic: Tel. +47 33 610 718
UK : Tel +44 7720 400 161
www.amebioscience.com/nordic/index.htm
|
|
